Iteos Therapeutics shares owned by Jpmorgan Chase & Co
Quarter-by-quarter ownership of Iteos Therapeutics (ITOS) shares owned by Jpmorgan Chase & Co
from 13F filings
Historical chart of Jpmorgan Chase & Co investment in Iteos Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Iteos Therapeutics held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Iteos Therapeutics by Jpmorgan Chase & Co
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-03-31 | $242k | 18k | 13.64 |
| 2023-12-31 | $255k | 23k | 10.95 |
| 2023-09-30 | $260k | 24k | 10.95 |
| 2023-06-30 | $271k | 20k | 13.24 |
| 2023-03-31 | $7.2M | 526k | 13.61 |
| 2022-12-31 | $11M | 584k | 19.53 |
| 2022-06-30 | $12M | 559k | 20.61 |
| 2022-03-31 | $7.3M | 227k | 32.18 |
| 2021-12-31 | $2.7M | 59k | 46.65 |
| 2021-03-31 | $338k | 9.9k | 34.05 |
| 2020-12-31 | $171k | 5.0k | 33.87 |
| 2020-09-30 | $96k | 4.0k | 24.10 |